BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 29445378)

  • 1. Fc-Glycosylation in Human IgG1 and IgG3 Is Similar for Both Total and Anti-Red-Blood Cell Anti-K Antibodies.
    Sonneveld ME; Koeleman CAM; Plomp HR; Wuhrer M; van der Schoot CE; Vidarsson G
    Front Immunol; 2018; 9():129. PubMed ID: 29445378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients with IgG1-anti-red blood cell autoantibodies show aberrant Fc-glycosylation.
    Sonneveld ME; de Haas M; Koeleman C; de Haan N; Zeerleder SS; Ligthart PC; Wuhrer M; van der Schoot CE; Vidarsson G
    Sci Rep; 2017 Aug; 7(1):8187. PubMed ID: 28811589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen specificity determines anti-red blood cell IgG-Fc alloantibody glycosylation and thereby severity of haemolytic disease of the fetus and newborn.
    Sonneveld ME; Koelewijn J; de Haas M; Admiraal J; Plomp R; Koeleman CA; Hipgrave Ederveen AL; Ligthart P; Wuhrer M; van der Schoot CE; Vidarsson G
    Br J Haematol; 2017 Feb; 176(4):651-660. PubMed ID: 27891581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skewed Fc glycosylation profiles of anti-proteinase 3 immunoglobulin G1 autoantibodies from granulomatosis with polyangiitis patients show low levels of bisection, galactosylation, and sialylation.
    Wuhrer M; Stavenhagen K; Koeleman CA; Selman MH; Harper L; Jacobs BC; Savage CO; Jefferis R; Deelder AM; Morgan M
    J Proteome Res; 2015 Apr; 14(4):1657-65. PubMed ID: 25761865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aglycosylation of human IgG1 and IgG3 monoclonal antibodies can eliminate recognition by human cells expressing Fc gamma RI and/or Fc gamma RII receptors.
    Walker MR; Lund J; Thompson KM; Jefferis R
    Biochem J; 1989 Apr; 259(2):347-53. PubMed ID: 2524188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro functional activity of IgG1 and IgG3 polyclonal and monoclonal anti-D.
    Kumpel BM
    Vox Sang; 1997; 72(1):45-51. PubMed ID: 9031501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison between Fc receptors for IgG1 and IgG3 on human monocytes and lymphocytes using anti-Rh antibodies.
    Zupańska B; Brojer E; Maślanka K; Hallberg T
    Vox Sang; 1985; 49(1):67-76. PubMed ID: 4013144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shedding of Fc receptor from mononuclear cells and their ability of binding IgG1 and IgG3 anti-Rh/D antibodies.
    Maślanka K; Erdei A
    Arch Immunol Ther Exp (Warsz); 1988; 36(1):15-22. PubMed ID: 3148299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen topography is critical for interaction of IgG2 anti-red-cell antibodies with Fc gamma receptors.
    Kumpel BM; van de Winkel JG; Westerdaal NA; Hadley AG; Dugoujon JM; Blancher A
    Br J Haematol; 1996 Jul; 94(1):175-83. PubMed ID: 8757532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fc receptors for IgG1 and IgG3 on human mononuclear cells--an evaluation with known levels of erythrocyte-bound IgG.
    Zupańska B; Thomson EE; Merry AH
    Vox Sang; 1986; 50(2):97-103. PubMed ID: 3515762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy.
    Kapur R; Kustiawan I; Vestrheim A; Koeleman CA; Visser R; Einarsdottir HK; Porcelijn L; Jackson D; Kumpel B; Deelder AM; Blank D; Skogen B; Killie MK; Michaelsen TE; de Haas M; Rispens T; van der Schoot CE; Wuhrer M; Vidarsson G
    Blood; 2014 Jan; 123(4):471-80. PubMed ID: 24243971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of human blood monocytes in erythrophagocytosis assay with anti-Rh antibodies.
    Brojer E; Gronkowska A; Zupańska B
    Arch Immunol Ther Exp (Warsz); 1986; 34(5-6):553-60. PubMed ID: 3496064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinctive role of IgG1 and IgG3 isotypes in Fc gamma R-mediated functions.
    Rozsnyay Z; Sármay G; Walker M; Maslanka K; Valasek Z; Jefferis R; Gergely J
    Immunology; 1989 Apr; 66(4):491-8. PubMed ID: 2523858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The functional activity of Fc gamma RII and Fc gamma RIII on subsets of human lymphocytes.
    Hadley AG; Zupanska B; Kumpel BM; Leader KA
    Immunology; 1992 Jul; 76(3):446-51. PubMed ID: 1356095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human monoclonal anti-D antibodies. II. The relationship between IgG subclass, Gm allotype and Fc mediated function.
    Kumpel BM; Wiener E; Urbaniak SJ; Bradley BA
    Br J Haematol; 1989 Mar; 71(3):415-20. PubMed ID: 2539182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycosylation pattern of anti-platelet IgG is stable during pregnancy and predicts clinical outcome in alloimmune thrombocytopenia.
    Sonneveld ME; Natunen S; Sainio S; Koeleman CA; Holst S; Dekkers G; Koelewijn J; Partanen J; van der Schoot CE; Wuhrer M; Vidarsson G
    Br J Haematol; 2016 Jul; 174(2):310-20. PubMed ID: 27017954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural characterization of the Man5 glycoform of human IgG3 Fc.
    Shah IS; Lovell S; Mehzabeen N; Battaile KP; Tolbert TJ
    Mol Immunol; 2017 Dec; 92():28-37. PubMed ID: 29031045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Affinity of the interaction between Fc gamma receptor type III (Fc gammaRIII) and monomeric human IgG subclasses. Role of Fc gammaRIII glycosylation.
    Galon J; Robertson MW; Galinha A; Mazières N; Spagnoli R; Fridman WH; Sautès C
    Eur J Immunol; 1997 Aug; 27(8):1928-32. PubMed ID: 9295028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences between the activities of human monoclonal IgG1 and IgG3 subclasses of anti-D(Rh) antibody in their ability to mediate red cell-binding to macrophages.
    Wiener E; Atwal A; Thompson KM; Melamed MD; Gorick B; Hughes-Jones NC
    Immunology; 1987 Nov; 62(3):401-4. PubMed ID: 3117677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin G1 Fc glycosylation as an early hallmark of severe COVID-19.
    Pongracz T; Nouta J; Wang W; van Meijgaarden KE; Linty F; Vidarsson G; Joosten SA; Ottenhoff THM; Hokke CH; de Vries JJC; Arbous SM; Roukens AHE; Wuhrer M; ;
    EBioMedicine; 2022 Apr; 78():103957. PubMed ID: 35334306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.